In vitro experiments of Yang, H. et al. demonstrated that CTSK high-expression contributed to the proliferation and migration of human non-small cell lung cancer (NSCLC) cells by activating the mammalian target of rapamycin (mTOR) signaling pathway (39). Here, CTSK is linked to non-small cell lung carcinoma.